| | | | | |
| $31,7150 | -0,14 % | $280,50M | $40,22K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,0900 | +0,00 % | $280,16M | $33,46K | |
TSI TCW Strategic Income Fund, Inc. | $4,3600 | +0,00 % | $279,70M | $324,88K | |
PAII Pyrophyte Acquisition Corp. II | $10,2800 | +0,20 % | $279,21M | $7,000 | |
| $14,6200 | -0,07 % | $279,07M | $328,88K | |
YDES YD Bio Limited Ordinary Shares | $4,9100 | +4,69 % | $279,07M | $35,17K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9890 | -0,01 % | $278,71M | $30,00 | |
RWAY Runway Growth Finance Corp. Common Stock | $6,6350 | -0,08 % | $278,70M | $473,94K | |
JILL J.Jill, Inc. Common Stock | $20,2100 | +0,00 % | $278,69M | $46,87K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0800 | +0,00 % | $278,19M | $681,90K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | +0,05 % | $278,12M | $23,89K | |
ACV Virtus Diversified Income & Convertible Fund | $26,3300 | -1,20 % | $278,09M | $20,60K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $2,0350 | -0,25 % | $277,93M | $367,39K | |
| $1,4300 | +0,00 % | $277,83M | $1,05M | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $3,0000 | +0,00 % | $277,66M | $62,85K | |
